期刊
EXPERT OPINION ON DRUG DELIVERY
卷 14, 期 4, 页码 449-452出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2017.1270938
关键词
HIV; microbicides; nanomedicine; pharmacokinetics; pre-exposure prophylaxis
资金
- Programa Gilead GENESE, Gilead Portugal [PGG/046/2015]
- Fundacao para a Ciencia e a Tecnologia (FCT) Portugal [VIH/SAU/0021/2011]
- FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE - Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal
- Portuguese funds through FCT/Ministerio da Ciencia Tecnologia e Inovacao [POCI-01-0145-FEDER-007274]
- FCT [SFRH/BPD/92934/2013]
- Fundação para a Ciência e a Tecnologia [VIH/SAU/0021/2011] Funding Source: FCT